Lunit and Leeds Teaching Hospitals NHS Trust are launching the world’s first prospective study of AI-powered breast screening in symptomatic clinics, using Lunit INSIGHT MMG. This innovative initiative aims to improve breast cancer detection,…
Continue Reading
In the relentless global battle against cancer, generative artificial intelligence (Gen AI) has emerged as a powerful tool in oncology’s arsenal. With the capacity to analyse vast datasets, simulate complex molecular interactions, and tailor…
Continue Reading
What You Should Know:
– Teladoc Health announced new strategic partnerships with musculoskeletal (MSK) care providers Sword Health & Hinge Health to offer employers access to a full suite of digital physical therapy solutions for…
Continue Reading
New research conducted by radiation oncology physicists at Miami Cancer Institute reveals remarkable precision in intracranial stereotactic radiosurgery (SRS) using an MR-guided radiotherapy system, the ViewRay MRIdian. Published in the International Journal of Radiation…
Continue Reading
The LungIMPACT trial – a collaborative study between UK academia, NHS hospitals and Qure.ai is now gathering real-world evidence of AI-assisted diagnosis of lung cancer.Using Qure.ai’s gXR solution, the LungIMPACT trial is triaging chest…
Continue Reading
RaySearch Laboratories AB is expanding its collaboration with P-Cure, a proton therapy provider, to integrate its RayStation and RayCare systems with P-Cure’s proton therapy system. This partnership enables seamless use of RaySearch’s automation, workflow…
Continue Reading
Mevion Medical Systems and RaySearch Laboratories are collaborating to pioneer groundbreaking solutions in proton therapy. Their partnership focuses on enhancing treatment planning, supporting adaptive therapy, advancing proton arc therapy, and facilitating FLASH proton therapy….
Continue Reading
Not-for-profit healthcare organisation St John of God Health Care has announced the rollout of an oncology information management system by Magentus across its hospitals in Australia.The Charm Evolution oncology IMS connects critical information about…
Continue Reading
The Department of Health and Social Care (DHSC) said Tuesday it will invest £30 million in innovative technology for the NHS. It said the investment would help cut waiting lists, speed up diagnosis and…
Continue Reading
A groundbreaking study reveals the effectiveness of liquid biopsy tests in guiding personalized treatment for non-small cell lung cancer (NSCLC) patients. Unlike conventional methods, these tests focus on circulating tumor DNA (ctDNA) levels, providing…
Continue Reading
